Thanks for pointing that out BK. I was going to respond yesterday but as a newbie I am limited to 3 posts a day and had used them up. I have to be very judicious with my posts until someone approves me for more. Anyway, yes my error was to just lump leukemia together as if it is one disease instead of a disease with many variants. K562 is myelogenous leukemia, for which K appears to be a quite an effective drug. There are other leukemias I was looking at in the patent for K (acute lymphoblastic leukemia, promyelocytic leukemia) where the cell lines are resistant to K. That said, this drug has amazing reach across tumor types. Well that is post 1 for today.
News 
Market Data 
Discover 
AI
